Drugs / IL-3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001269 | May 1991 → Feb 2001 | breast neoplasm, metastatic neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001269 ↗ |
| Known as | Interleukin-3 | “Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer” NCT00001269 ↗ |